Feedback tool to help men with prostate cancer decide on treatment
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a computer tool that analyzes your conversations with doctors. It aims to help you make a more informed choice about prostate cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with localized prostate cancer that hasn't spread
- You are about to discuss treatment options with your doctor for the first time
- OR you have been on active surveillance and are now considering definite treatment like surgery or radiation
- You can read and write in English
- You are 18 years or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an English computer tool that gives feedback during prostate cancer treatment visits. It aims to help you and your clinician make more informed, shared decisions about next treatment steps.
This study is testing an AI tool that helps explain prostate biopsy results in a way that is easier to understand. If you join, you'll review your pathology report with the help of this tool to see if it improves your understanding of your diagnosis.
This study tests a digital support tool that helps you understand your prostate cancer diagnosis and treatment options. It uses artificial intelligence to guide you through educational materials and connect you with support resources.
This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.
This study tests a digital tool to help men with early prostate cancer make treatment decisions. It aims to see if the tool improves communication and support during this stressful time.
This trial tests visual tools to help surgeons make better decisions for patients with early-stage prostate or kidney cancer. It may help you and your doctor choose the best treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.